AACE Rare Diseases and Hormone Disorders Webinar Series is pleased to present Homozygous Familial Hypercholesterolemia: Prevention of Aggressive Atherosclerosis Requires Aggressive Diagnosis and Treatment. This webinar is designed to help clinicians create a path to diagnosis when encountering a patient with Homozygous Familial Hypercholesterolemia (HoFH).
This disease was chosen due to its rarity, symptom complexity, and need for improved diagnostic and management strategies. The webinar will provide clinicians with the latest evidence-based clinical guidance and educational resources for diagnosing, managing, and treating HoFH. By highlighting the latest research and clinical advances, AACE aims to increase clinicians’ awareness, knowledge, and competence, ultimately improving the quality of care and outcomes for patients with this rare endocrine disease.
Upon completion of the program, participants will be able to:
1. Describe the diagnostic and testing approach in evaluating a patient with homozygous familial hypercholesterolemia.
2. Utilize evidence-based guidelines, algorithms, and consensus statements to diagnose and treat homozygous familial hypercholesterolemia.
3. Identify and treat long-term complications and comorbidities of homozygous familial hypercholesterolemia.
Eliot Brinton, MD, FAHA, FNLA, FACEPast President, American Board of Clinical LipidologyPresident, Utah Lipid CenterSalt Lake City, Utah
Lance Sloan, MD, MSE, FACE, FASN, FACP, FEAA, FASPCMedical DirectorTexas Institute for Kidney and Endocrine DisordersLufkin, TX
Starts 10/28/2024 | Expires 10/28/2025
Starts 10/31/2024 | Expires 10/31/2025